These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17682473)

  • 1. [A procedure for determining the oxidative modification of apolipoproteins in low-density lipoproteins].
    Ragino IuI; Polonskaia IaV; Sadovskiĭ EV
    Klin Lab Diagn; 2007 Jun; (6):14-7. PubMed ID: 17682473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Procedure for determination of oxidative modification of plasma fibrinogen].
    Ragino IuI; Baum VA; Polonskaia IaV; Gromov AA
    Klin Lab Diagn; 2007 Jan; (1):13-6. PubMed ID: 17385436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atherogenic oxidative and structural modification of low density lipoproteins in men with coronary atherosclerosis].
    Ragino IuI; Polonskaia IaV; Semaeva EV; Kashtanova EV; Kulikov IV; Cherniavskiĭ AM; Voevoda MI
    Kardiologiia; 2007; 47(11):14-8. PubMed ID: 18260958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease.
    Chiu HC; Jeng JR; Shieh SM
    Biochim Biophys Acta; 1994 Jan; 1225(2):200-8. PubMed ID: 8280789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced susceptibility of low-density lipoproteins to oxidation in coronary bypass patients with progression of atheroscerosis.
    De Rijke YB; Verwey HF; Vogelezang CJ; Van Der Velde EA; Princen HM; Van Der Laarse A; Bruschke AV; Van Berkel TJ
    Clin Chim Acta; 1995 Dec; 243(2):137-49. PubMed ID: 8747490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
    Ruotolo G; Ericsson CG; Tettamanti C; Karpe F; Grip L; Svane B; Nilsson J; de Faire U; Hamsten A
    J Am Coll Cardiol; 1998 Nov; 32(6):1648-56. PubMed ID: 9822092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoproteins and apolipoproteins in the young and familial risk of coronary atherosclerosis.
    Uiterwaal CS; Witteman JC; van Stiphout WA; Krauss XH; de Bruijn AM; Hofman A; Grobbee DE
    Atherosclerosis; 1996 May; 122(2):235-44. PubMed ID: 8769686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desialylated low density lipoproteins and atherosclerosis.
    Dousset N; Dousset JC; Soléra ML; Valdiguié P
    EXS; 1992; 62():158-63. PubMed ID: 1450583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of oxidized lipoproteins in the pathogenesis of atherosclerosis.
    Kita T; Yokode M; Ishii K; Kume N; Nagano Y; Arai H; Otani H; Ueda Y; Hara S
    Clin Exp Pharmacol Physiol Suppl; 1992; 20():37-42. PubMed ID: 1446408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
    Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
    Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New biochemical methods for evaluation of the oxidative-antioxidative potential of low-density lipoproteins].
    Ragino IuI; Voevoda MI; Kashtanova EV; Ivanova MV; Nikitin IuP
    Klin Lab Diagn; 2005 Apr; (4):11-5. PubMed ID: 16008245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
    Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
    Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy.
    Vasankari T; Ahotupa M; Toikka J; Mikkola J; Irjala K; Pasanen P; Neuvonen K; Raitakari O; Viikari J
    Atherosclerosis; 2001 Apr; 155(2):403-12. PubMed ID: 11254911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Key laboratory diagnostic biomarkers of coronary atherosclerosis].
    Ragino IuI; Cherniavskiĭ AM; Eremenko NV; Shakhtshneĭder EV; Polonskaia IaV; Tsymbal SIu; Ivanova MV; Voevoda MI
    Kardiologiia; 2011; 51(3):42-6. PubMed ID: 21627612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of modified tryptophan residues in apolipoprotein B-100 derived from copper ion-oxidized low-density lipoprotein.
    Yang C; Gu ZW; Yang M; Lin SN; Siuzdak G; Smith CV
    Biochemistry; 1999 Nov; 38(48):15903-8. PubMed ID: 10625456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood lipids, oxidative resistance of low density lipoproteins, concentration of fat-soluble antioxidants in older people and longevity in Novosibirsk].
    Shabalin AV; Nikitin IuP; Ragino IuI; Kashtanova EV; Pentegova VA
    Adv Gerontol; 2002; 10():64-8. PubMed ID: 12577693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease.
    Noma A; Yokosuka T; Kitamura K
    Atherosclerosis; 1983 Oct; 49(1):1-7. PubMed ID: 6651909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
    Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U
    Circulation; 1986 Jun; 73(6):1097-110. PubMed ID: 3698244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.